FDA Compliance for Peptide Therapy and BPC 157 Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines